Published Papers & Misc - YOSHIDA Soichiro

1. Toshinari Horie, Motohiro Fujiwara, Yuma Waseda, Hajime Tanaka, Soichiro Yoshida, Yasuhisa Fujii. Radiomics analysis using non-contrast computed tomography for predicting high-dependency unit admission in patients with acute pyelonephritis. Int J Urol. 2025.01; 32 (1): 121-123. ( PubMed, DOI )

2. Koichiro Kimura, Tatsuya Yamamoto, Junichi Tsuchiya, Soichiro Yoshida, Shuichi Yanai, Iichiro Onishi, Yasuhisa Fujii, Ukihide Tateishi. A diagnostic approach of various urethral diseases using multimodal imaging findings: comprehensive overview. Abdom Radiol (NY). 2024.12; 49 (12): 4416-4436. ( PubMed, DOI )

3. Kotaro Shimada, Motohiro Fujiwara, Daisuke Hirahara, Eichi Takaya, Soichiro Yoshida, Yasuhisa Fujii. Monitoring prostate cancer after low-dose-rate hemigland brachytherapy with delta-radiomics of diffusion-weighted magnetic resonance imaging. Int J Urol. 2024.12; 31 (12): 1443-1445. ( PubMed, DOI )

4. Soichiro Yoshida, Yuya Maezawa, Kensaku Ishihara, Naoki Inoue, Kenji Tanabe, Keita Izumi, Motohiro Fujiwara, Masahiro Toide, Takanobu Yamamoto, Sho Uehara, Saori Araki, Masaharu Inoue, Ryoji Takazawa, Noboru Numao, Yukihiro Ohtsuka, Hajime Tanaka, Yasuhisa Fujii. Outcomes and prognostic factors in patients with synchronous and metachronous oligometastatic urothelial carcinoma with visceral metastases. Int J Urol. 2024.11; 31 (11): 1234-1240. ( PubMed, DOI )

5. Hajime Tanaka, Yuki Fukawa, Kouhei Yamamoto, Kousuke Tanimoto, Akira Takemoto, Takayasu Mori, Hisashi Hasumi, Mayumi Kinoshita, Takumi Kanazawa, Asuka Furukawa, Koichiro Kimura, Hiroyuki Sato, Akihiro Hirakawa, Shohei Fukuda, Yuma Waseda, Soichiro Yoshida, Steven C Campbell, Yasuhisa Fujii. Prognostic Impact and Genomic Backgrounds of Renal Parenchymal Infiltration or Micronodular Spread in Nonmetastatic Clear Cell Renal Cell Carcinoma. Mod Pathol. 2024.11; 37 (11): 100590. ( PubMed, DOI )

6. Yuki Nakamura, Yudai Ishikawa, Masaki Kobayashi, Motohiro Fujiwara, Bo Fan, Shohei Fukuda, Yuma Waseda, Hajime Tanaka, Soichiro Yoshida, Yasuhisa Fujii. Location-specific diagnostic efficiency of photodynamic diagnosis-guided biopsy in bladder mapping biopsies. Int J Urol. 2024.11; 31 (11): 1263-1268. ( PubMed, DOI )

7. Yuya Maezawa, Masaki Kobayashi, Masanori Murakami, Ayumi Yamamura, Shotaro Naito, Hajime Tanaka, Soichiro Yoshida, Tetsuya Yamada, Yasuhisa Fujii. Prolonged hypoglycemia after the resection of pheochromocytoma in a hemodialysis patient. IJU Case Rep. 2024.11; 7 (6): 431-433. ( PubMed, DOI )

8. Kenji Tanabe, Shuichiro Kobayashi, Yuya Maezawa, Kensaku Ishihara, Naoki Inoue, Keita Izumi, Motohiro Fujiwara, Masahiro Toide, Takanobu Yamamoto, Sho Uehara, Saori Araki, Masaharu Inoue, Ryoji Takazawa, Noboru Numao, Yukihiro Ohtsuka, Hajime Tanaka, Soichiro Yoshida, Yasuhisa Fujii. Gustave Roussy Immune score as a prognostic biomarker in patients with platinum-refractory metastatic urothelial carcinoma treated with pembrolizumab: YUSHIMA study. Int J Clin Oncol. 2024.09; 29 (9): 1302-1310. ( PubMed, DOI )

9. Hiroki Tanaka, Soichiro Yoshida, Satoru Aoyama, Sadakatsu Ikeda, Junko Kunieda, Kenichi Ohashi, Shohei Fukuda, Yuma Waseda, Hajime Tanaka, Yasuhisa Fujii. A case of double-negative prostate cancer with BRCA2 mutation and high tumor mutation burden treated sequentially with olaparib and pembrolizumab IJU Case Rep. 2024.09; 7 (5): 395-398. ( PubMed, DOI )

10. Motohiro Fujiwara, Wataru Shimada, Minato Yokoyama, Anri Koyanagi, Hiroshi Shintaku, Shohei Fukuda, Yuma Waseda, Hajime Tanaka, Soichiro Yoshida, Yasuhisa Fujii. Durable response to nivolumab rechallenge in a patient with metastatic clear cell renal cell carcinoma. IJU Case Rep. 2024.07; 7 (4): 293-296. ( PubMed, DOI )

11. Masahiro Toide, Hajime Tanaka, Masaki Kobayashi, Motohiro Fujiwara, Yuki Nakamura, Shohei Fukuda, Koichiro Kimura, Yuma Waseda, Soichiro Yoshida, Ukihide Tateishi, Yasuhisa Fujii. Stepwise algorithm using computed tomography and magnetic resonance imaging for differential diagnosis of fat-poor angiomyolipoma in small renal masses: A prospective validation study. Int J Urol. 2024.07; 31 (7): 778-784. ( PubMed, DOI )

12. Masaki Kobayashi, Yoh Matsuoka, Sho Uehara, Hiroshi Tanaka, Motohiro Fujiwara, Yuki Nakamura, Yudai Ishikawa, Shohei Fukuda, Yuma Waseda, Hajime Tanaka, Soichiro Yoshida, Yasuhisa Fujii. Utility of positive core number on MRI-ultrasound fusion targeted biopsy in combination with PI-RADS scores for predicting unexpected extracapsular extension of clinically localized prostate cancer. Int J Urol. 2024.07; 31 (7): 739-746. ( PubMed, DOI )

13. Shintaro Asai, Masaki Kobayashi, Shohei Fukuda, Koichiro Kimura, Soichiro Yoshida, Yasuhisa Fujii. Significance of atypical nodules upgraded to category 3 in Prostate Imaging Reporting and Data System version 2.1 for prostate cancer diagnosis. Int J Urol. 2024.06; 31 (6): 693-695. ( PubMed, DOI )

14. Motohiro Fujiwara, Hajime Tanaka, Masaki Kobayashi, Yuki Nakamura, Bo Fan, Yudai Ishikawa, Shohei Fukuda, Kazuma Toda, Soichiro Yoshida, Minato Yokoyama, Ryoichi Yoshimura, Yasuhisa Fujii. Neoadjuvant Chemoradiotherapy Followed by Radical Cystectomy for Muscle-Invasive Bladder Cancer: Analysis of Efficacy and Safety in 119 Patients. Clin Genitourin Cancer. 2024.04; 22 (2): 193-200.e1.

15. Motohiro Fujiwara, Hajime Tanaka, Masaki Kobayashi, Yuki Nakamura, Bo Fan, Yudai Ishikawa, Shohei Fukuda, Kazuma Toda, Soichiro Yoshida, Minato Yokoyama, Ryoichi Yoshimura, Yasuhisa Fujii. Neoadjuvant Chemoradiotherapy Followed by Radical Cystectomy for Muscle-Invasive Bladder Cancer: Analysis of Efficacy and Safety in 119 Patients. Clin Genitourin Cancer. 2024.04; 22 (2): 193-200.e1. ( PubMed, DOI )

16. Ukihide Tateishi, Koichiro Kimura, Junichi Tsuchiya, Daisuke Kano, Tadashi Watabe, Norio Nonomura, Katsuhiko Saito, Kota Yokoyama, Ken Yamagiwa, Takuya Adachi, Yuji Kojima, Soichiro Yoshida, Yasuhisa Fujii. Phase I/IIa trial of 18F-prostate specific membrane antigen (PSMA) 1007 PET/CT in healthy volunteers and prostate cancer patients. Jpn J Clin Oncol. 2024.03; 54 (3): 282-291.

17. Ukihide Tateishi, Koichiro Kimura, Junichi Tsuchiya, Daisuke Kano, Tadashi Watabe, Norio Nonomura, Katsuhiko Saito, Kota Yokoyama, Ken Yamagiwa, Takuya Adachi, Yuji Kojima, Soichiro Yoshida, Yasuhisa Fujii. Phase I/IIa trial of 18F-prostate specific membrane antigen (PSMA) 1007 PET/CT in healthy volunteers and prostate cancer patients. Jpn J Clin Oncol. 2024.03; 54 (3): 282-291. ( PubMed, DOI )

18. Yudai Ishikawa, Hajime Tanaka, Motohiro Fujiwara, Yuki Nakamura, Shohei Fukuda, Yuma Waseda, Soichiro Yoshida, Minato Yokoyama, Yasuhisa Fujii. Incidence and predictors of intraoperative hypotension during transurethral bladder tumor resection with oral 5-aminolevulinic acid. Int J Urol. 2024.03; 31 (3): 238-244. ( PubMed, DOI )

19. Bo Fan, Minato Yokoyama, Masaki Kobayashi, Yuki Nakamura, Motohiro Fujiwara, Yudai Ishikawa, Shohei Fukuda, Yuma Waseda, Hajime Tanaka, Soichiro Yoshida, Yasuhisa Fujii. Incidence, risk factors, and significance of 20% decrease from new baseline estimated glomerular filtration rate after radical and partial nephrectomy within 2 years. Int J Urol. 2024.02; 31 (2): 119-124. ( PubMed, DOI )

20. Madoka Kataoka, Minato Yokoyama, Yuma Waseda, Masaya Ito, Masaki Kobayashi, Motohiro Fujiwara, Yuki Nakamura, Yudai Ishikawa, Shohei Fukuda, Hajime Tanaka, Soichiro Yoshida, Hitoshi Masuda, Yasuhisa Fujii. Longitudinal deterioration in lower urinary tract symptoms after artificial urinary sphincter implantation in patients with a history of pelvic radiation therapy. Low Urin Tract Symptoms. 2024.01; 16 (1): e12507. ( PubMed, DOI )